It has been stated that Rsk4, Sparc, and Hoxa9 function as oncogenes in ovarian cancer development, since they have less promotor methylation correlated with a high-grade tumor (Niskakoski et al., 2014). This evidence concerns the gene RPS6KA6 and ovarian carcinoma.